VD-Analysis: A Dynamic Network Framework for Analyzing Disease Progressions

Abstract

The progression of a disease associates with changes in genomic activity, but it remains a challenge to screen genetic biomarkers for clinical applications. The disease progression, in dynamic network methods (DNM), can be analogous to an animated film composed of discrete frames, where each frame represents a temporary state of the time-varying gene-gene interaction network. The major shortage therein is that the transition between two neighboring temporary states was beyond investigation. Here, we develop an updated computational methodology named after VD-analysis. Because single-gene biomarkers were not approved capable of representing a complex biological process, we firstly introduce V-structurea gene module composed of three genes and two interactions among themand define it as unit module. We then identify the perturbed pathways that mark the disease progression, followed with the V-structures identified which drive the pathway perturbations. Such driver V-structures can be taken as eligible biomarkers for clinical applications. To test the feasibility of this method, we apply it to a time course dataset of gene expression related to mouse type-II diabetes (T2D). Result indicates that the whole process of T2D is exactly divided into 3 stages and that the driver V-structures inferred for each stage are qualified biomarkers. In summary, our method contributes to the description of dynamic disease progression and the V-structure biomarkers facilitate the treatments of disease.

Clustering Ensemble Technology Based on Granular Computing to Extract Cervical Cancer Predictors

“…Nowadays, with the rapid development of high-throughput sequencing technology and the reduction of costs, the biomedical field has accumulated massive amounts of data. Using data analysis methods to apply biological big data to disease research has become a research hotspot in recent years [33][34][35]. For example, from gene expression data, identifying key genes as predictors for inferring the classification of tumors and normal samples is of great significance for clinical diagnosis.…”

Identification and Segregation of Genes with Improved Recurrent Neural Network Trained with Optimal Gene Level and Mutation Level Features

“…CHASM, trains an 86-predictive-feature random forest classifier. CanDrA creates an SVM with 95 characteristics from ten operational impact-based methods including SIFT and CHASM [23] [24] [25]. Machine learning-based algorithms have a pretty hard time picking "gold-standard driver genes (positive data)" as well as a collection of high-quality "nonfunctional passenger genes (negative data)" because the set of driver genes is considerably fewer than those of passenger genes.…”